Obesity drugs show potential in reducing addictions according to new study

A new study published in *Nature Medicine* shows that obesity drugs like Ozempic and Mounjaro may help reduce not only appetite but also addictions, including alcoholism. This research tracked nearly 216,000 diabetic veterans over five years. The study found that these drugs could improve impulse control and lower the risk of various substance use disorders. However, it also noted potential risks, such as pancreatitis and kidney stones. While the findings are promising, experts caution that the study's focus on mostly white male veterans may limit its applicability. Further research is needed to confirm these effects and explore the drugs' impact on mental health.